IL-17A Inhibitor Use Associated With Increased IBD Risk ...Middle East

The risk for inflammatory bowel disease is higher in patients with psoriasis or ankylosing spondylitis using IL-17A inhibitors than in those using apremilast, necessitating careful patient monitoring. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( IL-17A Inhibitor Use Associated With Increased IBD Risk )

Also on site :

• Assault suspect shot by police at Morgan Hill Safeway
• Sean ‘Diddy’ Combs Loses Bid to Delay Sex Trafficking Trial
• ‘He’s got MS-13 tattooed onto his knuckles’: Trump appears to hold up photoshopped image of Abrego Garcia’s hand